Other Species / Isoforms
  MOR-1 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S55
TGLGGNDSLCPQTGS
0 1
MOR-1 (human) TDLGGRDSLCPPTGS S57
MOR-1 iso5 (human) TDLGGRDSLCPPTGS S57
MOR-1 (mouse) TGLGGSHsLCPQTGS S55-p
MOR-1 (rat) TGLGGNDSLCPQTGS S55
T97-p
MYVIVRYtKMKtAtN
1 0
MOR-1 (human) MYVIVRYTKMKTATN T99
MOR-1 iso5 (human) MYVIVRYTKMKTATN T99
MOR-1 (mouse) MYVIVRYTKMKTATN T97
MOR-1 (rat) MYVIVRYtKMKtAtN T97-p
T101-p
VRYtKMKtAtNIyIF
1 0
MOR-1 (human) VRYTKMKTATNIYIF T103
MOR-1 iso5 (human) VRYTKMKTATNIYIF T103
MOR-1 (mouse) VRYTKMKTATNIYIF T101
MOR-1 (rat) VRYtKMKtAtNIyIF T101-p
T103-p
YtKMKtAtNIyIFNL
1 0
MOR-1 (human) YTKMKTATNIYIFNL T105
MOR-1 iso5 (human) YTKMKTATNIYIFNL T105
MOR-1 (mouse) YTKMKTATNIYIFNL T103
MOR-1 (rat) YtKMKtAtNIyIFNL T103-p
Y106-p
MKtAtNIyIFNLALA
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
MOR-1 (human) MKTATNIYIFNLALA Y108
MOR-1 iso5 (human) MKTATNIYIFNLALA Y108
MOR-1 (mouse) MKTATNIYIFNLALA Y106
MOR-1 (rat) MKtAtNIyIFNLALA Y106-p
Y166-p
CTMSVDRyIAVCHPV
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, inhibited
Treatment
  • DAMGO
  • EGF
  • H2O2
  • naloxone
  • PP2
MOR-1 (human) CTMSVDRyIAVCHPV Y168-p
MOR-1 iso5 (human) CTMSVDRYIAVCHPV Y168
MOR-1 (mouse) CTMSVDRYIAVCHPV Y166
MOR-1 (rat) CTMSVDRyIAVCHPV Y166-p
T180-p
VKALDFRtPRNAKIV
Upstream
Downstream
3 0
Effects on Modified Protein
  • receptor desensitization, altered
Treatment
  • DAMGO
MOR-1 (human) VKALDFRTPRNAKII T182
MOR-1 iso5 (human) VKALDFRTPRNAKII T182
MOR-1 (mouse) VKALDFRtPRNAKIV T180-p
MOR-1 (rat) VKALDFRtPRNAKIV T180-p
S261-p
LMILRLKsVRMLsGS
Upstream
Downstream
2 2
Effects on Modified Protein
  • receptor desensitization, altered
Putative in vivo kinases:
  • CAMK2A (human)
  • CAMK2A (rat)
Treatment
  • DAMGO
MOR-1 (human) LMILRLKsVRMLsGs S263-p
MOR-1 iso5 (human) LMILRLKSVRMLSGS S263
MOR-1 (mouse) LMILRLKSVRMLSGS S261
MOR-1 (rat) LMILRLKsVRMLsGS S261-p
S266-p
LKsVRMLsGSKEKDR
Upstream
Downstream
3 2
Effects on Modified Protein
  • receptor desensitization, altered
Putative in vivo kinases:
  • CAMK2A (human)
  • CAMK2A (rat)
Treatment
  • DAMGO
MOR-1 (human) LKsVRMLsGsKEKDR S268-p
MOR-1 iso5 (human) LKSVRMLSGSKEKDR S268
MOR-1 (mouse) LKSVRMLSGSKEKDR S266
MOR-1 (rat) LKsVRMLsGSKEKDR S266-p
S268
sVRMLsGSKEKDRNL
0 2
MOR-1 (human) sVRMLsGsKEKDRNL S270-p
MOR-1 iso5 (human) SVRMLSGSKEKDRNL S270
MOR-1 (mouse) SVRMLSGSKEKDRNL S268
MOR-1 (rat) sVRMLsGSKEKDRNL S268
Y336
SCLNPVLYAFLDENF
3 0
MOR-1 (human) SCLNPVLyAFLDENF Y338-p
MOR-1 iso5 (human) SCLNPVLYAFLDENF Y338
MOR-1 (mouse) SCLNPVLyAFLDENF Y336-p
MOR-1 (rat) SCLNPVLYAFLDENF Y336
S355-p
REFCIPTsstIEQQN
Downstream
1 0
Effects on Modified Protein
  • phosphorylation
  • receptor desensitization, altered
MOR-1 (human) REFCIPTSSNIEQQN S357
MOR-1 iso5 (human) REFCIPTSSNIEQQN S357
MOR-1 (mouse) REFCIPTSSTIEQQN S355
MOR-1 (rat) REFCIPTsstIEQQN S355-p
S356-p
EFCIPTsstIEQQNs
Upstream
0 1
Treatment
  • DAMGO
  • morphine
MOR-1 (human) EFCIPTSSNIEQQNs S358
MOR-1 iso5 (human) EFCIPTSSNIEQQNS S358
MOR-1 (mouse) EFCIPTSSTIEQQNs S356
MOR-1 (rat) EFCIPTsstIEQQNs S356-p
T357-p
FCIPTsstIEQQNsT
Upstream
Downstream
1 1
Effects on Modified Protein
  • phosphorylation
  • receptor desensitization, altered
Treatment
  • DAMGO
  • morphine
MOR-1 (human) FCIPTSSNIEQQNsT N359
MOR-1 iso5 (human) FCIPTSSNIEQQNST N359
MOR-1 (mouse) FCIPTSSTIEQQNsA T357
MOR-1 (rat) FCIPTsstIEQQNsT T357-p
S363-p
stIEQQNsTRVRQNt
Upstream
Downstream
11 5
Effects on Modified Protein
  • molecular association, regulation
  • receptor desensitization, altered
  • receptor internalization, altered
Kinase, in vitro:
  • PKCA (human)
Treatment
  • DAMGO
MOR-1 (human) SNIEQQNsTRIRQNt S365-p
MOR-1 iso5 (human) SNIEQQNSTRIRQNT S365
MOR-1 (mouse) STIEQQNsARIRQNt S363-p
MOR-1 (rat) stIEQQNsTRVRQNt S363-p
T370-p
sTRVRQNtREHPsTA
Upstream
Downstream
17 3
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
  • receptor desensitization, altered
  • receptor internalization, altered
Kinase, in vitro:
  • CAMK2A (human)
Putative in vivo kinases:
  • PKCA (rat)
Regulatory protein:
  • PKCA (rat)
  • RAGE (rat)
Treatment
  • DAMGO
  • etorphine
  • naloxone
MOR-1 (human) sTRIRQNtRDHPstA T372-p
MOR-1 iso5 (human) STRIRQNTRDHPSTA T372
MOR-1 (mouse) sARIRQNtREHPstA T370-p
MOR-1 (rat) sTRVRQNtREHPsTA T370-p
S375-p
QNtREHPsTANTVDR
Upstream
Downstream
21 3
MOR-1 (human)
S377-p
MOR-1 (mouse)
S375-p
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
  • receptor desensitization, altered
  • receptor internalization, altered
Kinase, in vitro:
  • GRK2 (human)
Treatment
  • DAMGO
  • etorphine
  • morphine
  • naloxone
  • nociceptin
MOR-1 (human) QNtRDHPstANTVDR S377-p
MOR-1 iso5 (human) QNTRDHPSTANTVDR S377
MOR-1 (mouse) QNtREHPstANtVDR S375-p
MOR-1 (rat) QNtREHPsTANTVDR S375-p
T376
NtREHPsTANTVDRT
5 1
MOR-1 (human) NtRDHPstANTVDRT T378-p
MOR-1 iso5 (human) NTRDHPSTANTVDRT T378
MOR-1 (mouse) NtREHPstANtVDRT T376-p
MOR-1 (rat) NtREHPsTANTVDRT T376
T379
EHPsTANTVDRTNHQ
5 1
MOR-1 (human) DHPstANTVDRTNHQ T381
MOR-1 iso5 (human) DHPSTANTVDRTNHQ T381
MOR-1 (mouse) EHPstANtVDRTNHQ T379-p
MOR-1 (rat) EHPsTANTVDRTNHQ T379
T394-p
LENLEAEtAPLP___
Upstream
Downstream
5 0
Effects on Modified Protein
  • receptor desensitization, altered
  • receptor internalization, altered
Treatment
  • DAMGO
  • etorphine
MOR-1 (human) LENLEAEtAPLP___ T396-p
MOR-1 iso5 (human) QPPLAVSMAQIFTRY M395
MOR-1 (mouse) LENLEAEtAPLP___ T394-p
MOR-1 (rat) LENLEAEtAPLP___ T394-p
-
gap
0 1
MOR-1 (human) gap -
MOR-1 iso5 (human) PPPTHREkTCNDYMK K410-m2
MOR-1 (mouse) gap -
MOR-1 (rat) gap -